What You Need to Know About De Novo MBC Research
Researchers are studying ways to treat de novo MBC, which is breast cancer that is first diagnosed at stage IV. Read about recent de novo MBC research and how to find MBC clinical trials.
Researchers are studying ways to treat de novo MBC, which is breast cancer that is first diagnosed at stage IV. Read about recent de novo MBC research and how to find MBC clinical trials.
Learn about the current research on HR-positive, HER2-Positive, Triple-Negative MBC, and other MBC subtypes from the 2021 St. Gallen International Breast Cancer Conference.
2% of breast cancer patients are diagnosed initially with stage IV metastatic disease.
Answer: False
Between 6-10% of breast cancer patients are diagnosed initially with stage IV metastatic disease. This is called “de novo” metastatic breast cancer.
You can learn more about de novo metastatic breast cancer here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905205/
You can find personal stories from women diagnosed de novo on MTT here: https://breastcancertrialtalk.org/2018/12/01/personal-stories-6/
Whether you were diagnosed with MBC de novo or have experienced a metastatic recurrence, a second opinion can help you learn more about your treatment options as well as make you more confident about the treatment plan you choose.
Below you can find articles that can help you think about when and how to get a second opinion. We’ve also included links to NCI-Designated Cancer Centers and NCI Community Oncology Research Programs. Centers included on these lists will offer a range of clinical trials.
About 6-10% of breast cancer patients are initially diagnosed at stage IV. This is often called “de novo” – from the beginning metastatic disease. This month we help share the unique experiences of some of these patients.
More personal stories from MetatastaticTrialTalk.org